NCT05515731View on ClinicalTrials.gov

Platelet Rich Plasma as a Treatment For Resistant Corneal Ulcers

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Cornea Ulcer
Interventions
BIOLOGICAL

Autologous platelet-rich plasma (PRP) eye drops

Autologous platelet-rich plasma (PRP) eye drops are used as a sole or adjunctive therapy in many ophthalmological conditions including dry eye, macular holes, retinitis pigmentosa and perforated corneal ulcers. Actions of PRP in these conditions are attributed to the plethora of growth and healing factors concentrated in different PRP preparations.

Trial Locations (1)

Unknown

Al-Azhar University, Cairo

All Listed Sponsors
collaborator

Al-Azhar University

OTHER

lead

Alaa Gamal

NETWORK

NCT05515731 - Platelet Rich Plasma as a Treatment For Resistant Corneal Ulcers | Biotech Hunter | Biotech Hunter